What is GDTC's relative strength rating?

GDTC ranks at the 46th percentile over 1 month, 21th percentile over 3 months, 41th percentile over 6 months, 19th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is GDTC in?

GDTC is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is GDTC in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). GDTC benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is GDTC?

GDTC currently shows a 20-day average daily range (ADR%) of 13.4%, a 90-day beta versus the S&P 500 of 0.04. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does GDTC have a seasonal pattern?

TickerStance computes GDTC's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what GDTC has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did GDTC last report earnings?

No SEC EDGAR filings are linked to GDTC in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

CytoMed Therapeutics Limited Ordinary Shares (GDTC)

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, CytoMed Therapeutics Limited Ordinary Shares (GDTC) has a 3-month relative strength percentile of 21 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 40. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 13.4%, relative volume 1.34×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month21pctile

6 month41pctile

1 year19pctile

Classic16IBD pctile

LDR10leadership

0 of 5 lenses lit · avg RS pctile 21

✓ADR%13.4%✓A/DA!RVOL1.34×!$ Vol$93K

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

§ Seasonality

10y · since 2023

Best monthOct on averageavg +23.54% · 100% win · n 3

Worst monthJan on averageavg -29.90% · 0% win · n 3

GDTC monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	GDTC Jan avg: -29.90% median: -27.76% win: 0% σ: 8.81% n: 3 2023-04-17 → 2026-07-31	GDTC Feb avg: -1.09% median: 6.06% win: 67% σ: 39.05% n: 3 2023-04-17 → 2026-07-31	GDTC Mar avg: -7.19% median: -7.41% win: 33% σ: 15.05% n: 3 2023-04-17 → 2026-07-31	GDTC Apr avg: -2.66% median: -1.53% win: 25% σ: 10.32% n: 4 2023-04-17 → 2026-07-31	GDTC May avg: -0.22% median: 0.13% win: 50% σ: 14.76% n: 4 2023-04-17 → 2026-07-31	GDTC Jun avg: -1.74% median: -3.36% win: 25% σ: 9.85% n: 4 2023-04-17 → 2026-07-31	GDTC Jul avg: 0.88% median: -11.34% win: 25% σ: 27.97% n: 4 2023-04-17 → 2026-07-31	GDTC Aug avg: -11.36% median: -18.16% win: 33% σ: 15.60% n: 3 2023-04-17 → 2026-07-31 (current)	GDTC Sep avg: 3.03% median: 3.69% win: 67% σ: 3.34% n: 3 2023-04-17 → 2026-07-31	GDTC Oct avg: 23.54% median: 10.55% win: 100% σ: 26.02% n: 3 2023-04-17 → 2026-07-31	GDTC Nov avg: -6.64% median: -2.49% win: 0% σ: 8.45% n: 3 2023-04-17 → 2026-07-31	GDTC Dec avg: 16.68% median: 32.79% win: 67% σ: 38.67% n: 3 2023-04-17 → 2026-07-31

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

46

3m

21

6m

41

1y

19

LDR

—

StageWeinstein stage analysis

Stage 4 · Decline✓

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · GDTC

Does the business back the chart?

No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
GDTC
21RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials

PEERS · Pharmaceutical Products

Same industry, closest relative strength

4 peers · by RS6M

VKTXViking Therapeutics, Inc41 VTVTvTv Therapeutics Inc. Class A Common Stock41 ZURAZura Bio Limited Class A Ordinary Shares41 LITSLite Strategy, Inc. Common Stock41

Public attention · GDTC

Is the crowd watching?

21/ 100 · vs its own 90-day norm▼ 15 vs 7dOverlooked

Weak relative strength and quiet attention. Little to read here either way.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

Reference

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2834

Float4.6Mshares

Shares out11.8Mshares

Market cap$11.8MNano Cap

FAQ

Frequently asked questions

What is GDTC's relative strength rating?: GDTC ranks at the 46th percentile over 1 month, 21th percentile over 3 months, 41th percentile over 6 months, 19th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is GDTC in?: GDTC is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is GDTC in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). GDTC benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is GDTC?: GDTC currently shows a 20-day average daily range (ADR%) of 13.4%, a 90-day beta versus the S&P 500 of 0.04. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does GDTC have a seasonal pattern?: TickerStance computes GDTC's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what GDTC has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

CytoMed Therapeutics Limited Ordinary Shares (GDTC) — Stance & relative strength

Lenses lit

Market backdrop

§ Seasonality

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

§ Seasonality

CytoMed Therapeutics Limited Ordinary Shares (GDTC) — Stance & relative strength

GDTC is not confirmed as a leader. 21 is not yet a leadership-grade RS read, Market Stance is 47.8

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?